3. Surface chemistry of bioactive ceramics 3.1 Mechanism of bone integration A synthetic biocompatible material hosted in bone tissue is, generally, encapsulated by fibrous connective tissue, and consequently the bone is not adherent to the synthetic material. A bioactive ceramic may be considered to bond to bone owing to its surface reactivity. But, in terms of surface reactivity, synthetic materials are more often degraded without bone integration. Smartly the bioactive ceramics form a specific surface protective layer in the body environ ment, through which they can integrate with bone.
A variety of acellular and cellular events are being con firmed to be involved in the process of integration of bioac tive ceramics with bone. These events may include ion ex change and structural rearrangement at the ceramic sur face, formation of bone mineral and/or organic phases, bone cell attachment and proliferation, and formation of extracel Figure 6 shows fracture toughnesses and Young's moduli of bioactive ceramics and other biocompatible materials, compared with those of the human cancellous and cortical bones. The restriction of bioactive ceramics in bone-repair ing surgery is due mostly to their poor fracture resistance. Particularly in replacement of bones such as femur and tibia, an implant is required to perform structural function under stringent load-bearing conditions. In these cases, the implant needs to reveal fracture strength and toughness above at least those of cortical bone, i.e., fracture resistance is the property of priority to bioactivity. For example, artifi cial joints, whose estimated number of implantations is an nually over 500,000 worldwide, are being made of non -bioactive metals such as those listed in Fig. 6 (examples of hip joint system in Fig. 7) . Major methods to anchor these polymethylmethacrylate (PMMA) glue,51) mechanical in terlocking through a macroporous layer ,52) and bone-bond ing through HA coatings.15) The argument is that, through these methods, clinical survivability of the implants may be less than a decade owing to their poor bone-bonding strength.
Bioactive surface functionalizations
From the compositional view of the functional groups effective for apatite nucleation, many of the non-bioactive materials have the potential to be bioactive. On the surfaces of such materials, bioactive surface functionalizations scheme fooooormation of a bioactive overlayer, sourcing it in situ on the material surfaces through controlled corrosion or structural variation. The bioactive surface layer is function ally graded as a function of depth toward the substrate, and therefore it is not a coating.
Chemical surface treatment of titanium metal53)-56) is a distinguished example of bioactive surface functionaliza tions. Titanium metal is simply immersed in NaOH aqueous solution and subsequently subjected to heat treatment to form a sodium titanate on its surface. The sodium titanate , which belongs to the bioactive compositions as indicated in Fig. 4 , can be controlled in phase type and thickness with the conditions of the NaOH and heat treatments. The produced sodium titanate overlayer is integrated onto the titanium surface through a functionally graded interfacial region in which the bioactivity and mechanical properties are gradually altered without phase discontinuity. Bewitch ingly, this chemical treatment can be applied to macro porous titanium to form bioactive sodium titanate uniformly along the surface and cross-sectional macrotextures, but do not induce a mechanical degradation of the titanium either in strength or in fatigue resistance. Through this treatment , titanium metal reveals apatite-forming ability in SBF , i.e., bioactivity, comparable to glass-ceramic A-W. Surface and SBF characterizations indicate that the apatite formation takes place on the metal via the same process as discussed above: formation of surface functional groups of Ti-OH via ion exchange of Na+ ion in the sodium titanate with H3O+ ion in the fluid, induction of apatite nucleation by the Ti-OH groups and simultaneously an acceleration of the apatite nucleation by IAP increase, and spontaneous growth of the apatite nuclei consuming calcium and phosphate ions in the fluid. The adhesive strength of apatite layer to the titanium substrate is far over 30MPa, since it also reveals graded in terface to the metal substrate.
The chemically surface-treated titanium metal was inves tigated into a number of animal models, revealing promising results toward clinical applications.57)-59) Figure 8 shows scanning laser micrographs of the cross-sections of untreat ed and surface-treated titanium metals implanted into the in tramedullar canal of rabbit femur for 3w. The surface-treat ed implant forms apatite on its surface, where bony forma tion is much more pronounced than around the untreated implant. Soon after this observation, the surface-treated im plant integrates with new bone through the apatite layer, whereas the untreated implant continues to have interven ing connective tissue. The bone-bonding strength of the sur face-treated titanium at an early implantation period up to 10w appears to be over 10 times higher in tension and 8 times higher in shear than untreated titanium. Macroporous titanium is subjected to the surface treatment to greatly en courage bony ingrowth into the porous structure and induce bone integration due to the apatite formation. Underlying the same scheme of NaOH and heat treat ments, titanium alloys such as Ti-6Al-4V, Ti-6Al-2Nb-Ta and Ti-15Mo-5Zr-3Al, and tantalum metal were shown to form functionally graded bioactive sodium titanate or sodi um tantalate on their surfaces.60)-62) Ohtsuki et al. 63 ) also reported formation of a bioactive titania gel layer on titani um metal by immersion in hydrogen peroxide solution con taining TaCl5. A Ce-TZP/Al2O3 composite was documented to form a bioactive zirconia gel layer on its surface by chemi cal treatments in aqueous HPO4, H2SO4, HCL or NaOH solution.64) This approach is based upon the in vitro obser vation of bonelike apatite formation on zirconia hydrogel .39) Fig. 7 . Artificial hip joint system; cup: polyethylene and/or titani um alloy, head: alumina, and stem: titanium alloy (photograph cour tesy of Kobe Steel Ltd., Kobe, Japan). 5. Bioactive hybrids: concept and perspectives As indicated in Fig. 6 in terms of Young's moduli, ceram ics and metals are much stiffer than human bone. While bone has to undergo remodeling in response to mechanical stimulation to become better adapted to load, a stiff implant may give rise to so-termed stress shielding around the host bone, consequently ensuing severe loss of bone tissue. In this context, flexible polymers are more attractive bone -repairing material candidates. However, in view of the sur face chemistry of bioactive ceramics, synthesis of a purely polymeric bioactive material is likely to be very difficult.
Organically modified silicate (ORMOSIL) early proposed by Schmidt et al. 65 ) is monolithic inorganic-organic compo site synthesized through sol-gel processes co-polymerizing organic components into silicate network at the molecular level. Owing to this structure, the ORMOSIL can even show a rubber-like elasticity, which is the property of interest as a biomaterial. The silicate in ORMOSIL can be precursored from the TEOS as in the silica gel which reveals bioactivity, upon which it is sufficient to derive a concept of bioactive ibility (Fig. 9) .
The bioactive feature of the ORMOSIL was first con ceived by Osaka and his co-workers.66) An ORMOSIL was derived by co-polymerizing TEOS with vinyltrimethoxysi lane (VTMS) in the presence of calcium acetate, and it formed bonelike apatite in SBF within 1d with an aid of cal cium release. Preparation of bioactive hybrids are currently attempted in system polydimethylsiloxane (PDMS)-CaO SiO2.67) As is expected, the properties of hybrids in this sys tem vary largely with factors such as sol-gel precursors and processes, composition, addition of the fourth component, and subsequent heat treatment.68)-70) Hydrolysis and poly condensation of PDMS, TEOS, TiPT and calcium nitrate give pore-and crack-free transparent monolithic hybrids in the system PDMS-CaO-SiO2-TiO2,70) whose properties are particularly noteworthy. Incorporation of TiO2 positively affects both the apatite-forming ability in SBF, indicative of bioactivity, and the flexibility of the hybrids. Figure 10 shows the bending strengths and strains to failure of hybrids in the system PDMS-CaO-SiO2-TiO2 as a function of TiO2 content, implying the possibility of bioactive hybrids with mechanical properties equivalent to those of the human can cellous bone. In another context, bioactive hybrids are regarded as a beneficial matrix for bioactive composites, as they can be widely controlled in flexibility to accommodate ductile or brittle materials as counter components. This ap proach may lead to a bioactive composite with different mechanical properties. 6. Biomimetic processes Typically, the cortical bone is composed of 41.0vol% (22 mass%) organic matrix of which 96vol% is collagen, 41.8 vol% (69 mass%) apatite mineral and 17.2vol% (9 mass %) water. Namely, over 99vol% of the bone is extracellular matrix, implying that the mechanical properties of the bone are exclusively due to this extracellular matrix. The bone is tough as well as flexible as shown in Fig. 6 , owing to the unique composite structure of the extracellular matrix: the apatite crystallites are submicroscopic and deposited on col lagen fibers, which are assembled into in the form of lamel lar sheets and further woven up into a three-dimensional structure. It is therefore largely expected that an acellular composite, in which bonelike apatite is coated uniformly on synthetic polymers textured as collagen fibers in the bone, will reveal mechanical properties equivalent to those of bone. The main concern is how to deposit the bonelike apatite on non-bioactive polymers with such complex microtextures. Biomimetic schemes are in this scope in that they pursue heterogeneous nucleation of a mineral phase on functionalized substrates in a patterned way from aqueous solution.
As described above, the bioactive glasses use surface functional groups such as Si-OH groups to induce nuclea tion and growth of apatite from blood plasma, and this can be reproduced in SBF. The prime version of an acellular biomimetic process proposed by Kokubo and his disciples71)-74) is based upon this phenomenon. In this biomi metic process, an organic polymer is placed in contact with granular particles of a CaO-SiO2-based glass in SBF. During this treatment, silicate ions rich in Si-OH groups release from the glass particles to adsorb onto the polymer surface , where they induce apatite nucleation in situ. The polymer is subsequently immersed in a solution highly supersaturated with respect to the apatite to make the apatite nuclei grow into homogeneous layer on the polymer surface. This process was shown to produce a dense and uniform bonelike apatite layer with a desired thickness on any kind of organic polymer. Subjecting the polymer surface to pre-treatments such as glow discharge before the apatite nucleation im proves adhesive strength of the apatite layer to the polymer substrate up to 10MPa. Figure 11 shows bonelike apatite coating on polyethyleneterephthalate (PET) fabric by this biomimetic process. In vivo studies show that the biomimet ic apatite on polymer surfaces mediate successfully an in tegration of the polymers with bone as biological apatite on bioactive ceramics.75), 76) More advanced versions of the biomimetic processes are intended for a more uniform bonelike apatite formation by specifying polymer targets and employing techniques that facilitates uniform incorporation of the Si-OH groups or other functional groups onto polymer surfaces. These tech niques include: immersion in sodium silicate solution,77) sol-gel incorporation of silica into silicone,78) vapor phase photografting and hydrolysis of VTMS on polyethylene,79) coupling and hydrolysis of iso-cyanatopropyltriethoxysilane on ethylene-vinylalcohol co-polymer,80) phospholylate coupling onto polyethylene or cotton fiber,81),82) attachment of SAMs or Langmuir-Blodgett films terminated with COOH groups,83),84) and carboxymethylation of chitin. 85) The SBF parameters, e.g., pH, ionic concentration and temperature, sensitively affect the growth and the composi tion and structure of the biomimetic apatite on the polymer surfaces.73),86) Rate of apatite growth increases appreciably with an increase either in ionic concentration or temperature of SBF. The most bonelike apatite is, however, produced in SBF whose ion concentrations including HCO3-and Cl-are conditioned to be equal to those in blood plasma. 87) 92) reported that the surface of glass-ceramic A-W forms bone matrix on rat osteoblast cell culture, sug gesting that a bioactive ceramic surface significantly facilitates the differentiation of osteogenic cells and subse quent apposition of bone matrix. This effect was, however, shown to be much more pronounced on bonelike apatite lay er pre-formed on the glass-ceramic in SBF (Fig. 12) . Using Bioglass_??_-type glass substrates, Ducheyene and Qui.19) sug gested that the bonelike apatite layer preformed in SBF con centrates osteoinductive growth factors on its surface in bio logically active forms, thereby providing a synergistic effect on osteoblastic differentiation and subsequent bone forma tion. This implies that in vitro formation of bonelike apatite layer may be more advantageous than merely utilizing the bioactive ceramics.
Clinical application of the osteogenic matrix coating,91) as termed by Ohgushi and his co-workers, is considered to be imminent. This technique plans to collect fresh bone mar row cells from the patient's own body and isolate the MSCs. The MSCs are subsequently subjected to culture-expansion, and cultured on a bioactive implant for formation of bone matrix. The implant with in vitro bone matrix coating in troduced into the surgery site is claimed to be as regenera tive as in vivo bone. Nonetheless, it is still unclear as to what degree bone-repairing strategy can be benefited by this type of bone tissue engineering. It appears that the relationship among bioactive ceramics, growth factors and bone cell functions should be further identified for future advance ment. More practically, the ceramics should be improved in applicability by being fabricated in the form of scaffolds whose textures are controlled as polymeric competitors. In this context, bone tissue engineering utilizing bioactive ce ramics may be significantly advanced in conjunction with bioactive surface functionalizations and biomimetic process es, which were discussed above. 8. Summary Bioactive ceramics and related technologies are clearly expanding their applications in clinical bone repairs. One major direction of the current research is toward bioactive materials that overcome the poor mechanical performances of the classical bioactive ceramics. Bioactive surface fun ctionalizations are being endeavored to prepare functionally S56 Special Review "Launching into The Great New Millennium" 
